Question Bank › Relationships widening on the customers' initiat

Relationships widening on the customers' initiative, with the numbers still catching up

Calls Tested
449
Answered YES
5
Hit Rate
1.1%
rare by design

Palatin Technologies, Inc. (PTN) — this company's answers

NO on the Q4 2023 call 2023-09-29 D
The model's full reasoning — Q4 2023 call → NOWe need to determine if the transcript shows that multiple existing relationships have recently widened by counterparty's own choice, and that the numbers are still catching up with management saying so. Let's examine the transcript for mentions of existing relationships widening. Key points: - Vyleesi is a commercial product. They have licensees outside U.S.: Fosun Pharma in China, Kwangdong in South Korea. Fosun reported first sale in Hainan Province. Kwangdong completed enrollment in Phase III trial. These are existing relationships, but are they widening? Fosun's first sale is a milestone, but it's not necessarily a widening of scope; it's the start of sales. Kwangdong completed enrollment, which is progress but not a widening of commitment. They are existing partners, but the transcript doesn't describe them as recently getting bigger in terms of scope or commitment beyond what was already agreed. - They entered into a strategic partnership with UpScriptHealth, a telemedicine company. That is a new relationship, not an existing one widening. - They mention "multiple ongoing discussions with potential partners" but that's not existing relationships. - For Vyleesi, they have six consecutive quarters of double-digit growth. But is that from existing relationships widening? The growth is in prescriptions and net revenue. They mention "refill rates, commercial insurance reimbursement and net revenue per prescription dispensed continued with impactful results." That could be from existing patients refilling, which is a form of existing customers taking more? But refills are not necessarily a widening of commitment; it's repeat purchases. The question asks about "existing relationships have recently widened, by the counterparty's own choice" such as existing customers adding locations, etc. Refills are not a widening; they are just repeat orders at usual size. The growth in prescriptions could be from new patients, not necessarily existing relationships widening. - They also mention "we are planning to initiate clinical programs as early as the end of this year" for the ED combination, but that's new. - For dry eye disease, they completed enrollment in MELODY-1, but that's a clinical trial, not a commercial relationship. - They mention "we have multiple ongoing discussions with potential partners" but that's not existing.

← Back to the full PTN analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won (customers, accounts, partners, distributors, members, or programs) that have, in the recent period, chosen to take a wider or deeper commitment than they had before — AND does management convey that the reported results reflect only the early part of these widenings, with most of their contribution still ahead? Answer YES when management's own words convey BOTH halves of this one phenomenon, in whatever form fits the business: (1) MULTIPLE EXISTING RELATIONSHIPS HAVE RECENTLY WIDENED, BY THE COUNTERPARTY'S OWN CHOICE. Management recounts that more than one already-established counterparty has stepped up its commitment in the recent period — in whatever form fits the industry, such as: existing customers adding locations, sites, users, lines, units, or departments; accounts that started with one product or use now taking additional ones; partners or distributors extending the relationship into new territories, categories, or scope; early deployments being broadened by the same counterparty; repeat orders arriving meaningfully larger than the initial ones; or relationships moving from an initial phase into a bigger committed phase. The widenings must be described as real and recent — decisions the counterparties actually made, with the resulting business signed, ordered, begun, or already flowing — not hoped for, in negotiation, or merely a pipeline. The pattern should span more than one relationship rather than a single large deal, and the growth should come from the counterparties choosing to take more, not merely from price increases pushed onto the same volumes. (2) THE NUMBERS ARE STILL CATCHING UP, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that these widened commitments have contributed only partially to the results being reported — because the expansions began recently, are still ramping toward their intended level, or have most of their delivery, rollout, or volume scheduled ahead — so the just-reported numbers understate the level of business these relationships have already committed to. Management should treat this widening pattern as meaningful to where the company is heading, discussing it as part of the company's trajectory rather than as a passing detail. Answer NO if the growth discussed comes mainly from winning brand-new customers, new markets, or new logos rather than from existing relationships getting bigger. NO if only one relationship is described as widening, however large. NO if the widenings are only hoped for, proposed, in pilot with no commitment, or contingent on decisions not yet made. NO if the increase is chiefly price increases on unchanged volumes, ordinary reorders at the usual size, or routine fluctuations in order timing. NO if the widened business is already fully reflected in the reported results, with no meaningful contribution still ahead. NO if management attributes the step-ups mainly to a one-time event, catch-up, pull-forward, or temporary condition it expects to fade. NO if the pattern appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
ZVIA Zevia PBC Q1 2022 2022-05-12 B
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
PTC PTC Inc. Q3 2017 2017-07-19 C+
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

ATI · Q1 2018 → YESThe question is: Does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won that have chosen to t...YES The transcript shows management describing multiple existing relationships (major engine OEM customers, Pratt & Whitney/UTC, Boeing, Airbus, and other aerospace/defense customers) that have recently widened commitments through production ramps, emergent demand above contractual share, and long-term agreements. It also conveys that these widenings are still ramping 2018 as an early phase of multi-year expansion, with most of the contribution ahead in 2019–2020.
GOGO · Q1 2016 → YESThe question is: Does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won that have chosen to t...YES The transcript shows management describing multiple existing relationships that recently widened: Delta increased its commitment to more than 600 2Ku aircraft (bringing total awarded over 1,000), and Air Canada extended its relationship to the entire wide-body international fleet. These are presented as recent decisions by established counterparties.
ZVIA · Q1 2022 → YESThe question is: Does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won that have chosen to t...

More from the question bank

Engine explained, runway namedDeliveries running ahead of the moneyInheritance being cashed inWhere the money wentRacing a clock somebody else setRepeat customers are now the ones asking forAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.